Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引：0
|
作者：
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构：
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2015年 / 71卷
关键词：
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 432
页数：7
相关论文
共 50 条
  • [31] Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
    Lee, Hae Won
    Kang, Woo Youl
    Jung, Wookjae
    Gwon, Mi-Ri
    Cho, Kyunghee
    Lee, Backhwan
    Seong, Sook Jin
    Yoon, Young-Ran
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (05): : 623 - 631
  • [32] Assessment of drug-drug interaction for silymarin
    Doehmer, Johannes
    Tewes, Bernhard
    Klein, Kai-Uwe
    Gritzko, Kristin
    Muschick, Holger
    Mengs, Ulrich
    TOXICOLOGY IN VITRO, 2008, 22 (03) : 610 - 617
  • [33] Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers
    Wu, Jia
    Jia, Li-Tao
    Shao, Li-Ming
    Chen, Jia-Min
    Zhong, Dan-Dan
    Xu, Song
    Cai, Jian-Ting
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (02) : 179 - 187
  • [34] Pharmacokinetic Drug-drug Interaction of Antibiotics Used in Sepsis Care in China
    Yu, Xuan
    Chu, Zixuan
    Li, Jian
    He, Rongrong
    Wang, Yaya
    Cheng, Chen
    CURRENT DRUG METABOLISM, 2021, 22 (01) : 5 - 23
  • [35] DRUG-DRUG INTERACTION PREDICTION ASSESSMENT
    Zhou, Jihao
    Qin, Zhaohui
    Sara, Quinney K.
    Kim, Seongho
    Wang, Zhiping
    Hall, Stephen D.
    Li, Lang
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (04) : 641 - 657
  • [36] Pharmacokinetic Drug-Drug Interaction Study of Ranolazine and Metformin in Subjects With Type 2 Diabetes Mellitus
    Zack, Julia
    Berg, Jolene
    Juan, Axel
    Pannacciulli, Nicola
    Allard, Martine
    Gottwald, Mildred
    Zhang, Heather
    Shao, Yongwu
    Ben-Yehuda, Ori
    Jochelson, Phil
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (02): : 121 - 129
  • [37] Pharmacokinetic Drug-Drug Interaction Assessment of LCZ696 (an Angiotensin Receptor Neprilysin Inhibitor) With Omeprazole, Metformin or Levonorgestrel-Ethinyl Estradiol in Healthy Subjects
    Gan, Lu
    Jiang, Xuemin
    Mendonza, Anisha
    Swan, Therese
    Reynolds, Christine
    Nguyen, Joanne
    Pal, Parasar
    Neelakantham, Srikanth
    Dahlke, Marion
    Langenickel, Thomas
    Rajman, Iris
    Akahori, Mizuki
    Zhou, Wei
    Rebello, Sam
    Sunkara, Gangadhar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (01): : 27 - 39
  • [38] Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects
    Spaans, E
    van den Heuvel, MW
    Schnabel, PG
    Peeters, PAM
    Chin-Kon-Sung, UG
    Colbers, EPH
    Sitsen, JMA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) : 423 - 429
  • [39] Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
    Ding, Yan
    Guan, Huida
    Yan, Yingxuan
    Chen, Yan
    Huang, Cheng
    HELIYON, 2023, 9 (11)
  • [40] In vivo assessment of potential for UGT-inhibition-based drug-drug interaction between sorafenib and tapentadol
    Karbownik, Agnieszka
    Miedziaszczyk, Milosz
    Grabowski, Tomasz
    Stanislawiak-Rudowicz, Joanna
    Jazwiec, Radoslaw
    Wolc, Anna
    Grzeskowiak, Edmund
    Szalek, Edyta
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
12345